1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Pharmaceuticals & Healthcare, Global, Deal Summary
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2020
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, August 2020
2.2.1 Siemens Healthineers to Acquire Varian for USD16.4 Billion
2.2.2 Johnson & Johnson Raises USD7.5 Billion in Public Offering of Notes
2.2.3 Johnson & Johnson to Acquire Momenta Pharma
2.2.4 Gilead Sciences and Tango Therapeutics Enter into Collaboration
2.2.5 Royalty Pharma Raises USD6 Billion in Private Placement of Notes
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2020
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2020
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type
3.1 Pharmaceuticals & Healthcare, Global, M&A, August 2020
3.1.1 Top M&A Deals in August 2020
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2020- August 2020
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2020
3.2.1 Top Equity Offering Deals in August 2020
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2020- August 2020
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2020
3.3.1 Top PE/VC Deals in August 2020
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2020
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2020
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, March 2020-August 2020
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2020-August 2020
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2020
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2020- August 2020
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2020
3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2020
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2020- August 2020
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2020- August 2020
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2020- August 2020
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2020
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2020
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2020
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2020- August 2020
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2020- August 2020
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2020- August 2020
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), March 2020- August 2020
4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, August 2020
4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2020
4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2020
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, August 2020
5.1.1 Oncology - Deals of the Month
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, August 2020
5.2.1 Central Nervous System - Deals of the Month
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, August 2020
5.3.1 Infectious Diseases - Deals of the Month
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, August 2020
5.4.1 Cardiovascular - Deals of the Month
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, August 2020
5.5.1 Immunology - Deal of the Month
5.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, August 2020
5.6.1 Metabolic- Deals of the Month
5.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Disorders, Deals, August 2020
5.7.1 Gastrointestinal - Deals of the Month
6 Deal Summary by Geography7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors8 Further InformationList of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, August 2020
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), August 2020
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, August 2020
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2020- August 2020
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, August 2020
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, August 2020
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, March 2020- August 2020
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), August 2020
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2020- August 2020
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), August 2020
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2020- August 2020
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), March 2020- August 2020
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), August 2020
Table 27: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, March 2020- August 2020
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), August 2020
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, August 2020
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, August 2020
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, August 2020
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 37: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Table 38: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), August 2020
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), August 2020
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2020- August 2020
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, March 2020- August 2020
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), August 2020
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), August 2020
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2020- August 2020
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, March 2020- August 2020
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), March 2020- August 2020
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, March 2020- August 2020
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), March 2020- August 2020
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), August 2020
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 32: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 33: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), March 2020- August 2020
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), March 2020- August 2020